» Articles » PMID: 862227

Purification and Characterization of Human Liver-specific Membrane Lipoprotein (LSP)

Overview
Date 1977 Mar 1
PMID 862227
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

A liver-specific lipoprotein (LSP) which is present in 105,000 g supernatants of human liver has previously been shown to produce a lesion resembling chronic active hepatitis in rabbits immunized with human liver fractions containing this lipoprotein. In addition, it has been implicated as the principal target antigen involved in the liver cell cytotoxicity exhibited in vitro by lymphocytes from patients with chronic active hepatitis. The organ-specificity and species cross-reactivity of LSP is confirmed. Although very labile, is has been prepared in a stable form by gel filtration of Sepharose 6B in a Tris buffer containing 1 mm disodium EDTA. LSP is also stable in a borate buffer containing EDTA but is unstable in a number of other buffer systems tested. When prepared by this method it contains approximately 2% albumin as the only detectable contaminant. Gel filtration studies on the apoprotein of LSP revealed that it has an apparent mol. wt of between 4 X 10(6) and 20 X 10(6). SDA-polyacrylamide gel electrophoresis indicated that the lipoprotein may be composed of up to thirteen sub-units of different molecular sizes.

Citing Articles

Autoantibody against a 78 kDa membrane protein of HepG2 cell in the sera of patients with alcoholic liver diseases.

Numata T, Kato J, Kohgo Y, Katsuki S, Kondo H, Niitsu Y J Gastroenterol. 1995; 30(6):751-7.

PMID: 8963393 DOI: 10.1007/BF02349642.


Changes of antigen expression on human hepatoma cell lines caused by sodium butyrate, a differentiation inducer.

Saito H, Tada S, Ebinuma H, Tsunematsu S, Kagawa T, Kumagai N J Gastroenterol. 1994; 29(6):733-9.

PMID: 7874268 DOI: 10.1007/BF02349279.


Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity.

Manns M, Meyer zum Buschenfelde K, Hess G Gut. 1980; 21(11):955-61.

PMID: 7450561 PMC: 1419291. DOI: 10.1136/gut.21.11.955.


Immune responses to liver membrane antigens in patients with cystic fibrosis and liver disease.

Mieli-Vergani G, Psacharopoulos H, Nicholson A, Eddleston A, Mowat A, Williams R Arch Dis Child. 1980; 55(9):696-701.

PMID: 7436533 PMC: 1626989. DOI: 10.1136/adc.55.9.696.


Antibodies to a human liver membrane lipoprotein (LSP) in primary biliary cirrhosis.

Tsantoulas D, Perperas A, Portmann B, Eddleston A, Williams R Gut. 1980; 21(7):557-60.

PMID: 7429318 PMC: 1419884. DOI: 10.1136/gut.21.7.557.


References
1.
DAMELIO V, Perlmann P . The distribution of soluble antigens in cellular structures of rat liver. Exp Cell Res. 1960; 19:383-98. DOI: 10.1016/0014-4827(60)90016-1. View

2.
BARTLETT G . Phosphorus assay in column chromatography. J Biol Chem. 1959; 234(3):466-8. View

3.
Perlmann P, DAMELIO V . Soluble antigens in microsomes and other cell-fractions of rat liver. Nature. 1958; 181(4607):491-2. DOI: 10.1038/181491a0. View

4.
Poulik M . Starch gel electrophoresis in a discontinous system of buffers. Nature. 1957; 180(4600):1477-9. DOI: 10.1038/1801477a0. View

5.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View